Scientists of the RWTH Aachen developed a simple epigenetic test to track cellular aging. The method does not require a reference-sample of the corresponding early passage and provides a simple quality control to determine the state of cellular aging.
As induced pluripotent stem cells (iPS) do not reveal cellular aging and are predicted passage zero, the identification of high quality induced iPS might also be possible.
On behalf of RWTH Aachen, PROvendis offers access to rights for commercial use as well as the opportunity for further co-development.
In case of interest we are pleased to inform you about the current patent status.